Opthea Ltd (OPT)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Opthea Ltd (OPT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013559
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Opthea Ltd (Opthea), formerly Circadian Technologies Ltd is a provider of research and development of angiogenesis and vascular leakage-based treatments for cancer focusing on vascular endothelial growth factors. The company’s pipeline products comprise VEGF-C, VEGF-D and VEGFR-3. Opthea’s diagnostic service portfolio includes diagnosis of cancers of unknown primaries. Its lead compound, OPT-302 is used to blocks two members of the vascular endothelial growth factors, namely VEGF-C and VEGF-D which cause blood vessels to grow and leak. The company’s VEGF-D diagnostics is a prognostic indicator of number of tumor types, and VEGF-C diagnostics, an indicator of survival rate. It partners with healthcare and diagnostic centers. Circadian is headquartered in Melbourne, Victoria, Australia.

Opthea Ltd (OPT) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Opthea Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Opthea Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Opthea Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Opthea Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Opthea Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Opthea Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Opthea Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Licensing Agreements 11
Opthea Enters Into Licensing Agreement With Selexis For Wet AMD Product 11
Equity Offering 12
Opthea Raises USD2.3 Million in Rights Offering of Shares 12
Opthea Raises USD26.7 Million in Private Placement of Shares 13
Opthea Raises USD5.3 Million in Rights Offering of Shares 14
Circadian Raises USD11.1 Million in Second Tranche of Private Placement of Shares 15
Circadian Raises USD3 Million in Rights Offering of Shares 17
Circadian Technologies Raises USD1 Million in First Tranche of Private Placement 19
Circadian Technologies Completes Private Placement Of Shares For US$1 Million 20
Opthea Ltd – Key Competitors 21
Opthea Ltd – Key Employees 22
Opthea Ltd – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Opthea Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Opthea Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Opthea Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Opthea Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Opthea Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Opthea Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Opthea Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Opthea Enters Into Licensing Agreement With Selexis For Wet AMD Product 11
Opthea Raises USD2.3 Million in Rights Offering of Shares 12
Opthea Raises USD26.7 Million in Private Placement of Shares 13
Opthea Raises USD5.3 Million in Rights Offering of Shares 14
Circadian Raises USD11.1 Million in Second Tranche of Private Placement of Shares 15
Circadian Raises USD3 Million in Rights Offering of Shares 17
Circadian Technologies Raises USD1 Million in First Tranche of Private Placement 19
Circadian Technologies Completes Private Placement Of Shares For US$1 Million 20
Opthea Ltd, Key Competitors 21
Opthea Ltd, Key Employees 22
Opthea Ltd, Subsidiaries 23

★海外企業調査レポート[Opthea Ltd (OPT)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PepVax Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary PepVax Inc (PepVax) is a biotechnology company that develops novel therapeutics for the treatment of cancer. The company provides pipeline product candidate portfolio such as HCA587, which is being developing to treat hepatocellular carcinoma and TFDP3, a drug candidate which is being used f …
  • Southwestern Energy Company:企業の戦略・SWOT・財務情報
    Southwestern Energy Company - Strategy, SWOT and Corporate Finance Report Summary Southwestern Energy Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • The New York Times Company (NYT):企業の財務・戦略的SWOT分析
    The New York Times Company (NYT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Venn Life Sciences Holdings Plc (VENN):企業の財務・戦略的SWOT分析
    Summary Venn Life Sciences Holdings Plc (Venn Life Sciences), formerly Armscote Investment Company Plc is a contract research organization that offers drug development, clinical trial management and resourcing solutions. The organization offers drug development services such as clinical pharmacology …
  • TissueGen Inc:企業の製品パイプライン分析2018
    Summary TissueGen Inc (TissueGen) is a medical device company that develops fiber for advance drug delivery, nerve regeneration and tissue engineering. The company’s products comprise pharmaceutical fibers, growth factor fibers and stent. It offers pharmaceutical fibers and growth factor fibers. Tis …
  • The Hershey Co:企業のM&A・事業提携・投資動向
    The Hershey Co - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Hershey Co Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • VWR International LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary VWR International LLC (VWR), a subsidiary of Avantor Performance Materials Inc, is a provider of product and service solutions to laboratory and production companies. The company offers products such as adhesive dispensers, adhesive labels, adhesive slides, agarose and acrylamide, air freshe …
  • Shine Medical Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary Shine Medical Technologies Inc (Shine Medical) is a manufacturer and supplier of medical tracers and cancer treatment elements. The company’s products include molybdenum-99 is the parent isotope of technetium 99m for diagnosing and staging multitude of diseases, including cancer and heart di …
  • Panasonic Corporation:企業の戦略・SWOT・財務分析
    Panasonic Corporation - Strategy, SWOT and Corporate Finance Report Summary Panasonic Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Viasat Inc:企業の戦略・SWOT・財務分析
    Viasat Inc - Strategy, SWOT and Corporate Finance Report Summary Viasat Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Bank of Communications Ltd (601328):企業の財務・戦略的SWOT分析
    Bank of Communications Ltd (601328) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Umicore SA:企業の戦略・SWOT・財務分析
    Umicore SA - Strategy, SWOT and Corporate Finance Report Summary Umicore SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • IndigoVision Group plc (IND):企業の財務・戦略的SWOT分析
    Summary IndigoVision Group plc (IndigoVision) is a developer, manufacturer and distributor of end-to-end IP security management systems. The company’s products include management software, cameras and encoders, specialized cameras, body worn video, integration and recorders. Its camera and encoder’s …
  • PLx Pharma Inc (PLXP):製薬・医療:M&Aディール及び事業提携情報
    Summary PLx Pharma Inc (PLx Pharma) is a pharmaceutical company that develops patent-protected delivery systems. The company offers products such as PLxGuard delivery system, PLxGuard pipeline products, and PL1100 and PL1200 ibuprofen products. Its PLxGuard delivery system are used in enhancement of …
  • International Paper APPM Limited:企業の戦略・SWOT・財務情報
    International Paper APPM Limited - Strategy, SWOT and Corporate Finance Report Summary International Paper APPM Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Arbuthnot Latham & Co., Limited:企業の戦略・SWOT・財務情報
    Arbuthnot Latham & Co., Limited - Strategy, SWOT and Corporate Finance Report Summary Arbuthnot Latham & Co., Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • ArmorWorks Enterprises, LLC:企業の戦略・SWOT・財務情報
    ArmorWorks Enterprises, LLC - Strategy, SWOT and Corporate Finance Report Summary ArmorWorks Enterprises, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Dongfang Electric Corporation Ltd (1072):電力:M&Aディール及び事業提携情報
    Summary Dongfang Electric Corporation Ltd (DEC), a subsidiary of Dongfang Electric Corporation, is a power equipment and services company. It designs, manufactures and sells power generation equipment, including turbines for hydro, thermal, and nuclear power generation, wind turbine generator sets, …
  • Petrofac Ltd (PFC)-石油・ガス分野:企業M&A・提携分析
    Summary Petrofac Limited (Petrofac) is an oilfield services company that provides integrated services to production and processing industries. It designs and builds oil and gas facilities; operates, maintains and manages facilities on behalf of its customers and trains personnel. It also develops an …
  • meteocontrol GmbH:電力:M&Aディール及び事業提携情報
    Summary Meteocontrol GmbH (meteocontrol) a subsidiary of S.A.G. Solar GmbH & Co. KG, is a renewable energy company which offers photovoltaic monitoring solutions. The company's product portfolio includes data loggers, WEB'logs, portals, sensor system, grid feed-in management or power control, SCADA …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆